L. S. Bilbao

FRI0269 COMPARATIVE STUDY OF INFLIXIMAB VERSUS ADALIMUMAB IN REFRACTORY UVEITIS DUE TO BEHÇET’S DISEASE. NATIONAL MULTICENTER STUDY OF 177 CASES

F. Romero, J. Nolla, S. Castañeda, 2019, Poster Presentations.

FRI0270 APREMILAST IN NON-ULCER MANIFESTATIONS IN BEHçET’S DISEASE. MULTICENTER STUDY OF 32 CASES IN CLINICAL PRACTICE

G. Espinosa, S. Castañeda, S. Ojeda, 2019, Poster Presentations.

FRI0202 SHORT AND LONG-TERM FOLLOW-UP OF APREMILAST THERAPY IN REFRACTORY SKIN LUPUS LESIONS

S. Castañeda, R. Blanco, M. González‐Gay, 2019, Poster Presentations.

AB1077 ANTI-IL6-RECEPTOR TOCILIZUMAB IN GRAVES’ ORBITOPATHY. MULTICENTER STUDY OF 46 PATIENTS IN CLINICAL PRACTICE

S. Castañeda, E. Tomero, R. Blanco, 2019, Abstracts Accepted for Publication.

SAT0215 APREMILAST IN REFRACTORY ORAL AND/OR GENITAL ULCERS IN BEHÇET’S DISEASE. MULTICENTER STUDY OF 49 CASES IN CLINICAL PRACTICE

G. Espinosa, S. Castañeda, S. Ojeda, 2019, Saturday, 15 June 2019.